A planned Medicare pilot program that would have expanded access to popular weight‑loss drugs known as GLP‑1s has been ...

Novo Nordisk’s oral semaglutide met its main goal in a late-stage trial for children with type 2 diabetes, paving the way for a U.S. launch of the Ozempic pill. Amazon is entering active GLP-1 care ...

Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...

An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid ...

“Peptide” is maybe the buzziest word in health care right now — but, as usual, the social media mania masks a much more ...

Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.

An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Peptides are all anyone wants ...

Protein is having a moment. The rise of people using GLP-1 drugs to lose weight, along with the overall changing consumer ...

You finally took the plunge and started taking a GLP-1 drug to improve your health. You’re keeping up with your GLP-1 pill or ...

NATICK, MA, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- NeuroDex and Stanford Researchers Publish First ...

A dietitian has explained the reasons why weight-loss drugs such as Wegovy and Mounjaro may not deliver rapid results for ...